Skip to main content
رجوع
MNMD logo

Mind Medicine (MindMed) Inc.

جودة البيانات: 100%
MNMD
NASDAQ Healthcare Biotechnology
KWD 18.48
▲ KWD 0.69 (3.88%)
القيمة السوقية: 1.40B
نطاق اليوم
KWD 17.82 KWD 19.06
نطاق 52 أسبوعًا
KWD 4.70 KWD 19.62
حجم التداول
25,445
متوسط 50 يوم / 200 يوم
KWD 12.71 / KWD 9.85
الإغلاق السابق
KWD 17.79

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (631 نظير)

المقياس السهم وسيط القطاع
P/E -7.6 0.2
P/B 4.2 3.0
ROE % -64.1 3.5
Net Margin % 3.8
Rev Growth 5Y % 9.7
D/E 0.0 0.2

السعر المستهدف للمحللين

Hold
KWD 28.00 +51.5%
ربحية السهم المستقبلية
-KWD 1.94
الإيرادات المقدّرة
16.67M

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 2.93
KWD 2.93 – KWD 2.93
820.93M 4
FY2029 KWD 0.99
KWD 0.99 – KWD 0.99
493.15M 4
FY2028 -KWD 0.54
-KWD 1.89 – KWD 2.95
215.98M 10

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-26 -KWD 0.48 -KWD 0.56 -16.7%
2025-11-06 -KWD 0.52 -KWD 0.78 -50.0%
2025-07-31 -KWD 0.38 -KWD 0.50 -31.6%
2025-05-08 -KWD 0.36 -KWD 0.35 +2.8%
2025-03-06 -KWD 0.33 -KWD 0.41 -24.2%
2024-11-07 -KWD 0.29 -KWD 0.27 +6.9%
2024-08-13 -KWD 0.30 -KWD 0.48 -60.0%
2024-05-08 -KWD 0.66 -KWD 0.60 +9.1%

Dividend History

Yield

0.00%

Payout Ratio

0.00%

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

النقاط الرئيسية

Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -131.56M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-64.06%
ROIC-37.53%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
0.00
Current Ratio6.29
Interest Coverage-30.34

التقييم

P/E Ratio
-7.60
Forward P/EN/A
P/B Ratio4.20
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -183.79M
ROE -64.06% ROA -41.76%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -131.56M
ROIC -37.53% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.00 Current Ratio 6.29
Interest Coverage -30.34
Dividends
Dividend Yield 0.00% Payout Ratio 0.00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -7.60 Forward P/E N/A
P/B Ratio 4.20 P/S Ratio N/A
PEG Ratio -0.19 Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 83.77 Fwd Earnings Yield N/A
FCF Yield -9.42%
Market Cap 1.40B Enterprise Value 1.14B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0.0 0.0 0.0 0.0 0.0
Net Income -183.79M -108.68M -95.73M -56.80M -93.04M
EPS (Diluted) -2.06 -0.15 -2.44 -1.84 -3.40
Gross Profit 0.0 -527,000.0 -3.16M -3.22M 0.0
Operating Income -166.31M -103.92M -93.87M -66.33M -93.85M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 440.10M 302.15M 124.54M 169.99M 164.00M
Total Liabilities 107.77M 60.70M 46.41M 19.08M 12.34M
Shareholders' Equity 332.33M 241.45M 78.13M 150.92M 151.66M
Total Debt 0.0 21.85M 14.13M 72,000.0 0.0
Cash & Equivalents 257.84M 273.74M 99.70M 142.14M 133.54M
Current Assets 419.32M 281.62M 103.87M 146.06M 137.22M
Current Liabilities 66.70M 38.85M 32.25M 17.89M 10.41M